2017 Annual Meeting Institute 1 Notebook
2017 Annual Meeting Institute 1 Notebook
Accumulating data support the efficacy of psychopharmacologic interventions for a number of psychiatric disorders in youth; however, in parallel, studies increasingly reveal a clearer picture of the adverse effects or side effects profiles of these treatments. This advanced Institute seeks to review and apply current data related to efficacy of psychotropic medications in youth, as well as the prevalence and management of medication-related adverse effects. The Institute presents recent clinical trial data and data related to efficacy and side effect management of selected medications in pediatric patients with anxiety, depressive, bipolar, autism spectrum, tic and obsessive-compulsive disorders, as well as attention-deficit/hyperactivity disorder. Case presentations are utilized to illustrate pragmatic aspects of adverse effects and tolerability issues with second generation antipsychotics, stimulants, and antidepressants, as well as evidence-based management strategies for these adverse effects.
65.00